Mental Health News
A team of researchers at Georgetown University, Washington, explored the effectiveness of mindfulness-based stress reduction (MBSR) in treating anxiety disorders. The study is published in the JAMA Psychiatry.
276 participants with anxiety disorders were randomly assigned 8 weeks of the weekly mindfulness-based stress reduction program or the antidepressant escitalopram course. Then, their anxiety levels were assessed with the Clinical Global Impression of Severity scale (CGI-S).
The results revealed that mindfulness-based stress reduction intervention for the treatment of anxiety disorders is non-inferior to pharmacotherapy.
The authors remarked: “Our study provides evidence for clinicians, insurers, and health care systems to recommend, include, and provide reimbursement for mindfulness-based stress reduction [in treatment for anxiety disorders].”
To Know More You May Refer To
Hoge, E. A., Bui, E., Mete, M., Dutton, M. A., Baker, A. W., & Simon, N. M. (2023). Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial. JAMA psychiatry, 80(1), 13–21. https://doi.org/10.1001/jamapsychiatry.2022.3679